China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A single arm, prospective, exploratory study on the use of remimazolam besylate combined with hydromorphone for sedation and analgesia during perioperative ablation procedures'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136740

Registration Time: 2026/11/15

Type: Interventional study

Primary Sponsor: The First Hospital of Lanzhou University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=353323

Published by HT Digital Content Services with permission from Health Daily Digest....